← Back to Clinical Trials
Recruiting NCT03044509
NCT03044509 Diagnosis of Tuberculosis in Swiss Children
◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT03044509 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Children's Hospital Basel |
| Condition | Tuberculosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 190 participants |
| Start Date | 2017-05-12 |
| Primary Completion | 2026-12 |
Trial Parameters
Condition Tuberculosis
Sponsor University Children's Hospital Basel
Study Type OBSERVATIONAL
Phase N/A
Enrollment 190
Sex ALL
Min Age N/A
Max Age 17 Years
Start Date 2017-05-12
Completion 2026-12
All Conditions
Interventions
Secreted cytokine assayIntracellular cytokine assay
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
1. The primary objective is to improve the sensitivity of novel immunodiagnostic tests for detection of TB disease in children. 2. The secondary objective is to determine biomarkers that discriminate children with TB infection and disease.
Eligibility Criteria
Inclusion Criteria: * all children / adolescents \< 18 years of age undergoing evaluation for TB exposure, infection or disease. Exclusion Criteria: * children / adolescents with TB infection or disease who have already been started on anti-mycobacterial treatment, children who have been treated for TB previously.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology